The enforcement of all our laws seems to depend who is in charge of enforcing them.

I shared this article on April 7, 2025, referencing our Fed AG Jan 31, 2019 decision. This was during President Trump’s administration. It is typical for these things to take some time to reach a conclusion. But preceding this date, several people held the office of AG or acting AG, which led up to this conclusion.   Jeff Sessions, Rod Rosenstein, Matthew Whitaker   Below that link to the article, I am sharing the information provided by perplexity.ai when I asked it: what comorbidities issues are generally involved with addiction.

I asked perplexity.ai what the DOJ has done regarding discrimination of pts with SUD/OUD since Jan 2019, and it came up with NADA. With our new Fed AG Pam Bondi, I doubt if she will pursue anything as well. I guess we have another law that is enforced at the discretion of  “who is in power.”

DOJ Considers Opioid Use Disorder an ADA Covered Disability and Pursues Claims Against a Provider for Refusing Medical Services to Opioid Users

what comorbidities issues are generally involved with addiction

Comorbidities associated with addiction, also known as substance use disorders (SUDs), are common and can significantly complicate treatment and recovery. These comorbidities span mental health disorders, medical conditions, and behavioral issues. Below is an overview of the most prevalent comorbidities:

### **Mental Health Disorders**
1. **Depression and Anxiety Disorders**: These are among the most frequent comorbid conditions. Many individuals use substances to self-medicate, which can create a vicious cycle of dependency[1][2].
2. **Bipolar Disorder**: Substance abuse often exacerbates mood instability in individuals with bipolar disorder[1][3].
3. **Post-Traumatic Stress Disorder (PTSD)**: Trauma survivors may turn to substances to cope with distressing memories and emotions[1][2].
4. **Personality Disorders**:
– **Borderline Personality Disorder (BPD)**: Impulsivity and emotional dysregulation in BPD increase vulnerability to substance use.
– **Antisocial Personality Disorder (ASPD)**: Individuals with ASPD are more likely to engage in substance abuse due to impulsivity and disregard for societal norms[1][3].
5. **Psychotic Disorders**: Schizophrenia frequently co-occurs with SUDs, complicating treatment adherence and symptom management[1][3].

### **Medical Conditions**
1. **Infectious Diseases**: Injection drug use is linked to a higher risk of HIV/AIDS and hepatitis.
2. **Cardiovascular Issues**: Stimulant use can lead to hypertension, arrhythmias, and heart attacks.
3. **Liver and Gastrointestinal Problems**: Chronic alcohol or drug use can cause liver damage and gastrointestinal disorders.
4. **Diabetes and Cancer**: Addiction may exacerbate these systemic conditions by hindering proper management[4][6].

### **Behavioral Disorders**
1. **Eating Disorders**: Conditions like anorexia, bulimia, and binge eating disorder often co-occur with SUDs due to shared risk factors such as low self-esteem[1][3].
2. **Gambling Disorder**: Both behaviors share underlying vulnerabilities in brain reward systems[1].

### **Challenges in Diagnosis and Treatment**
Diagnosing comorbidities is challenging due to overlapping symptoms, stigma, and limited integration between mental health and addiction treatment services. Untreated comorbidities often worsen outcomes by increasing relapse risks and reducing treatment effectiveness[2][6].

### **Integrated Care Approach**
Effective management requires a multidisciplinary approach that simultaneously addresses addiction and comorbid conditions through personalized treatment plans. This includes pharmacological interventions, psychotherapy, and social support systems tailored to individual needs[1][2].

Addressing these comorbidities holistically improves recovery outcomes and enhances quality of life for individuals struggling with addiction.

Citations:
[1] https://www.serenityspringsrecovery.com/blog/common-comorbidities-with-substance-use-disorders/
[2] https://www.euda.europa.eu/spotlights/comorbid-substance-use-and-mental-health-problems_en
[3] https://www.unodc.org/documents/drug-prevention-and-treatment/UNODC_Comorbidities_in_drug_use_disorders.pdf
[4] https://footprintstorecovery.com/comorbid-medical-conditions-addiction/
[5] https://www.youtube.com/watch?v=5RbEotf0jqI
[6] https://thephoenixrc.com/blog/addiction-recovery/handling-comorbidities-with-substance-use-disorder/
[7] https://www.ncbi.nlm.nih.gov/books/NBK571451/
[8] https://nida.nih.gov/research-topics/co-occurring-disorders-health-conditions
[9] https://altacenters.com/addiction-resources/comorbidity/
[10] https://www.helpguide.org/mental-health/addiction/substance-abuse-and-mental-health


Answer from Perplexity: pplx.ai/share

FULL HEARING: Facebook Whistleblower Testifies Before Senate Judiciary Committee

Beyond Medical Paternalism: Restoring Control to the Individual

Beyond Medical Paternalism: Restoring Control to the Individual

https://www.cato.org/free-society/spring-2025/beyond-medical-paternalism-restoring-control-individual

Heavy-handed government policies often undermine patient autonomy, restricting the medicines they can take, the doctors they can see, and the information they can access.

rom the earliest days of their training, health professionals are taught the critical ethical principle of respecting their patients’ autonomy. But in the broader realm of public policy, that principle often gets trampled under the weight of bureaucracy.

Government agencies frequently dictate which doctors a patient can see, restrict access to new medications, and even regulate the information pharmaceutical companies can share with consumers.

Autonomy in health care is not just an academic ideal. It’s about empowering individuals to make decisions about their lives, their bodies, and their well-being. But while doctors are bound by the principle of informed consent, government policies often assume that individuals are incapable of making informed choices about their own health.

The doctrine of informed consent—the right to accept or refuse medical treatment even at personal risk—is a relatively modern concept. Barely a century ago, it was commonly accepted that doctors could do whatever they thought was in the best interests of their patients, regardless of a patient’s wishes or priorities.

Dr. Jeff Singer in Scrubs

Dr. Jeffrey Singer, who has worked in private practice as a general surgeon for over 35 years, at his medical office in Phoenix. (Photo by Duane Furlong Studios)

This model of care sometimes had tragic results. From 1932 to 1972, the Tuskegee Syphilis Study saw government health agencies withhold treatment from nearly 400 black men to observe the progression of the disease while intentionally not informing participants that a cure for the disease existed. Even as late as the 1970s, some doctors routinely withheld diagnoses from cancer patients, fearing the emotional impact would derail treatment.

“Today, informed consent is a cornerstone of the patient-doctor relationship. But outside the exam room, government policies often ignore this principle, restricting individual autonomy in profound ways.”

Today, informed consent is a cornerstone of the patient-doctor relationship. But outside the exam room, government policies often ignore this principle, restricting individual autonomy in profound ways.

Barriers to Choice: Licensing Laws and Monopolies

State licensing laws, originally framed as a means of protecting public health, now often serve as barriers to patient choice. In the 19th century, the American Medical Association lobbied aggressively for laws that restricted entry into the medical profession. Over time, similar restrictions spread to other health professions, creating a complex web of regulations that limits competition and stifles innovation.

This dynamic is evident in the turf battles that play out in state legislatures, where professional groups vie to protect their monopoly over specific practices. Patients are left with fewer options, and the assumption persists that the government knows better than individuals who should provide their care.

But as economist Milton Friedman noted, licensing laws rarely ensure quality care. Instead, they raise costs and limit access. Private accrediting organizations could fill this role, providing certifications that help patients make informed choices while opening the door to greater competition and innovation.

“Without [medical licensing], they would have no power to do harm,” Friedman told a group of medical professionals at the Mayo Clinic in 1978. “Why is that the case? Because the key to the control of medicine starts with who is admitted to practice.”

The Freedom to Access Information

Health and Human Services Secretary Robert F. Kennedy Jr., who was nominated by President Trump with a mandate to “Make America Healthy Again,” has argued passionately against the “priesthood” of the medical establishment, calling for greater transparency and personal responsibility in health care. Yet he supports banning direct-to-consumer advertising by pharmaceutical companies—a move that would restrict patients’ ability to access vital information about treatment options.

The US Supreme Court has repeatedly affirmed that the First Amendment protects the free exchange of scientific information. Prohibiting pharmaceutical ads would make clinicians the sole gatekeepers of knowledge, further disempowering patients. Policymakers should reject such bans and embrace policies that enhance transparency and trust.

Ending the Prescription Monopoly

Since 1938, the federal government has controlled which medications Americans can legally purchase. In 1951, Congress expanded that authority, requiring prescriptions for certain drugs—a decision previously made by pharmaceutical companies. While intended to protect public health, this policy has driven up costs, delayed access to life-saving treatments, and forced patients to navigate unnecessary bureaucratic hurdles.

Patients in other countries often access medications over the counter that require a prescription in the United States. Reforming this system—whether through small changes or sweeping overhauls—could help restore patient autonomy and reduce health care costs without compromising safety.

The Right to Choose Substances

Prohibition didn’t work for alcohol, and it hasn’t worked for drugs. Yet for over a century, government policies have criminalized substances for medical and recreational use, creating black markets and fueling violence.

In many cases, driving these drugs underground makes them far more dangerous and deadly. For example, opioids, when used responsibly, are less harmful to organ systems than alcohol or tobacco. But prohibition has pushed these drugs into the black market, where adulteration and unknown potency make them far more dangerous.

More recently, lawmakers have set their sights on food additives. Proposals like the Do or Dye Act and the Stop Spoonfuls of Fake Sugar Act aim to ban certain dyes and sweeteners. Instead of letting consumers make their own choices, these measures would increase costs and limit freedom—all while ignoring policies that drive the use of cheaper additives, such as agricultural subsidies and import tariffs on sugar that incentivize the use of high-fructose corn syrup.

Embracing Harm Reduction

Harm reduction is a pragmatic approach to health care that seeks to minimize the risks associated with certain behaviors without endorsing them. It’s why doctors prescribe medications for smoking cessation or manage chronic conditions linked to lifestyle choices.

But federal and state laws often block harm-reduction strategies for drug users. In five states, distributing fentanyl test strips—tools that can detect lethal contaminants—is illegal. A federal law known as the “crack house statute” prohibits overdose prevention centers, where drug users are monitored and opioid antidotes and oxygen administered. Such centers have saved lives in 16 countries since 1986.

These policies not only infringe on personal autonomy but also exacerbate the problems they claim to address. By embracing harm reduction, policymakers could save lives and empower individuals to make safer choices.

Toward a Healthier, Freer Future

In my forthcoming book, Your Body, Your Health Care (Cato Institute, April 2025), I explore the many ways government paternalism has eroded personal autonomy, often with devastating consequences. Restoring this autonomy isn’t just a matter of principle—it’s a path to better health outcomes and a freer society.

If the Trump administration is serious about “making America healthy again,” its first priority should be to return control to the individual.

DOJ Considers Opioid Use Disorder an ADA Covered Disability and Pursues Claims Against a Provider for Refusing Medical Services to Opioid Users

According to this article, Selma Medical had a policy to not prescribe narcotic controlled substances to any pts. This was SIX YEARS ago, why has there not been a lot of lawsuits against practitioners that refuse/decline to treat pts whose health issues require the use of  opioids?

DOJ Considers Opioid Use Disorder an ADA Covered Disability and Pursues Claims Against a Provider for Refusing Medical Services to Opioid Users

https://www.healthlawadvisor.com/doj-considers-opioid-use-disorder-an-ada-covered-disability-and-pursues-claims-against-a-provider-for-refusing-medical-services-to-opioid-users

The U.S. Department of Justice reached a January 31, 2019 settlement of an American with Disabilities Act (“ADA”) Title III complaint against health care provider Selma Medical Associates relating to provision of medical services to an individual with opioid use disorder (“OUD”).  The settlement is notable for health care providers and employers as it makes clear that DOJ considers OUD as a disability under the ADA thereby triggering the full panoply of ADA rights for those with OUD.

The DOJ complaint was premised on the alleged refusal of Selma Medical to schedule a new patient family practice appointment after the patient disclosed he takes Suboxone.  Suboxone is a prescription medication approved by the Food and Drug Administration for treating OUD.  The complaint further alleged that Selma refused to treat patients with narcotic controlled substances, including Suboxone, thus imposing “eligibility criteria that screen out or tend to screen out individuals with OUD.”  The compliant also alleged a failure to make reasonable accommodations to policies, practices or procedures when necessary “to afford such goods, services, facilities, privileges, advantages, or accommodations to individuals with disabilities.”

Under the settlement, Selma agreed to:

  1. Not discriminate or deny services on the basis of disability, including OUD;
  2. Not use eligibility standards, criteria or methods of administration that tend to deny benefits on the basis of disability including OUD;
  3. To modify its policies as necessary;
  4. To draft and submit within 30 days for DOJ approval a non-discrimination policy and to remove any inappropriate existing policies;
  5. After DOJ approval, to adopt and disseminate to all employees the new non-discrimination policy;
  6. To train all management and employees within 60 days and annually for three years as to the new policy and ADA compliance with the initial training conducted live, with a Q&A opportunity, and by a trainer to be approved by DOJ;
  7. Submit compliance reports to DOJ for three years; and
  8. To pay compliant $30,000 in damages and a civil penalty to the U.S. of $10,000.

The DOJ-Selma Medical settlement is highly significant in an environment where in 2015, OUD affected 2 million people aged 12 and over (Drug and Alcohol Dependence, Vol. 169, Dec. 2016, pp. 117-127) and .6 million persons aged 12 or over had heroin use disorder (id.) and the lifetime percentage of individuals with Diagnostic and Statistical Manual-IV prescription OUD among adults 18 and over had more than doubled from 1.4% in 2001-2002 to 2.9% in 2012-2013 (id.), and likely higher today.  And, of course, this does not include those who are OUD for reasons other than prescriptions.  This means that health care providers are highly likely to encounter significant numbers of potentially challenging OUD patients.  DOJ has now made clear that providing the full range of care and services to such patients is required under the ADA – and that any failure to do so can lead to litigation, costly settlements and adverse publicity.

All employers, not just health care providers, should take note of this settlement as it clearly means that employers will also need to reasonably accommodate employees who seek time off for treatment or other accommodations unless the employer cannot show the requested accommodations would be an undue hardship.

The Selma Medical settlement is also a reminder that health care providers should make sure they have appropriate non-discrimination policies in place as required pursuant to Health and Human Services regulations for compliance under Title III of the ADA, the Rehabilitation Act of 1973, and the non-discrimination requirements of Section 1557 of the Affordable Care Act.  We can assist with any questions regarding the required policies and other issues as to compliance with the ADA, the Rehab Act and Section 1557.

Don’t let the facts get in the way and interfere with your agenda

I asked www.perplexity.ai the following fairly (IMO) complex question. It looked at 58 different sources to come up with this answer/explanation.  It has been several years since the DEA has published what they were spending to fight the war on drugs. Recent estimates are that it is 120 – 140 million/yr. I have read recently that the 1970 CSA directed the DEA to deal with the diversion of pharma opioids. That might explain why we don’t see the DEA involved with all the illegal opioids and various illegal substances showing up on our streets. Our DEA is part of our FED DOJ, and they have an array of laws they are in charge of enforcing, and sometimes their interpretation(s) of the laws. Which our SCOTUS declared a year ago that Fed agencies do not have the statutory authority to make new interpretations of the laws they are in charge of enforcing. SCOTUS has no authority to enforce our laws. That is the duty of the DOJ. Unfortunately, many bureaucrats and politicians seem to work under the premise that “no one is above the law… except those who are in charge of enforcing our laws”. So, those entities that choose to enforce or ignore our laws can pretty much establish their own agenda. Their agenda prevails, and the FACTS are just ignored, and “experts” come forward to contradict and deny the facts are untrue and/or meaningless.

Most of your footnotes reference the use of opioids and treating SUD. Little/no deal with treating chronic pain. A couple of years ago the DEA stated that < 1% of pharma opioids were being diverted, but followed up by reducing pharma production quota. The National agreement was a mediated agreement – no court case. It would seem that there was no consideration of those agreements causing chronic pain patients to have access to their prescribed, medically necessary medications. Who determines what adequate pain therapy is? The vast majority of OD/poisoning is with opioids. The illegal opioids are known to be coming primarily from China & Mexican cartels. Over the last decade, pharma opioid production quotas have been reduced > 50%, and yet OD/poisoning is up 6-7 times. Are politicians & bureaucrats ignoring the real source of OD/poisoning – illegal opioids?


The opioid overdose crisis has shifted dramatically toward illicit synthetic opioids like fentanyl, yet policy and regulatory responses often lag behind this reality. Here’s an analysis of the disconnect between the current overdose drivers and policy focus:

### **1. Overdose Trends vs. Policy Focus**
– **Illicit opioids dominate deaths**: Over 80% of opioid-related deaths now involve illicitly manufactured fentanyl, with China supplying precursors and Mexican cartels producing/distributing the drug ([4][5][8]). Meanwhile, pharmaceutical opioid prescriptions have declined by over 50% since 2012 ([9]).
– **Policy emphasis persists on prescription opioids**: Recent settlements (e.g., 2022 distributor agreement) and 2025 DEA regulations ([3]) continue targeting pharmaceutical supply chains, despite <1% diversion rates for prescription opioids ([8]). These policies risk restricting access for chronic pain patients without addressing the primary overdose driver: illicit fentanyl.

### **2. Chronic Pain Patient Challenges**
– **Stricter quotas and oversight**: The DEA’s 2025 opioid production quotas and CMS care coordination edits (90 MME/day threshold) prioritize reducing prescription volumes ([3]). However, guidelines still emphasize **individualized care**, noting opioids may be appropriate for some chronic pain patients when benefits outweigh risks ([1][2]).
– **Documentation burdens**: Physicians face increased administrative requirements to justify opioid therapy, which can delay or deter treatment for legitimate patients ([1]).

### **3. Political and Regulatory Blind Spots**
– **Partisan divides**:
– **Democrats** increasingly focus on pharmaceutical accountability and treatment access ([10]), which risks overemphasizing prescription opioids’ role.
– **Republicans** prioritize border security and illicit drug interdiction ([10]), but underfund harm reduction strategies (e.g., naloxone distribution, overdose prevention centers) proven to save lives ([6][7]).
– **International policy gaps**: While China and Mexico are central to fentanyl production, U.S. efforts to disrupt supply chains remain inconsistent. China’s 2019 fentanyl ban reduced direct exports but not precursor flows, and Mexican enforcement varies by administration ([4][5][8]).

### **4. Data vs. Action**
– **Overdose deaths vs. prescription trends**: Between 2012 and 2025:
– Pharmaceutical opioid prescriptions dropped by ~60% ([3][9]).
– Overdose deaths increased 6-7x, driven by illicit fentanyl ([7][8]).
– **Misaligned solutions**: Funding from opioid settlements often supports law enforcement rather than addiction treatment or pain management programs ([7][10]). For example, only 12% of settlement funds in 2023–2024 were allocated to harm reduction or patient care ([7]).

### **5. Who Decides “Adequate Pain Therapy”?**
– **Guidelines vs. reality**: The CDC’s 2022 guidelines ([2]) and state policies ([1]) delegate decisions to clinicians but impose structural barriers (e.g., dosage caps, prior authorization). This creates a “chilling effect,” where physicians avoid opioids even for appropriate cases due to liability concerns.
– **Patient exclusion**: Chronic pain advocacy groups report being sidelined in policy discussions, with settlement negotiations ([3][8]) and legislation ([10]) prioritizing public health agencies and law enforcement over patient representatives.

### **Conclusion**
Politicians and regulators are disproportionately focused on legacy issues tied to prescription opioids, despite overwhelming evidence that illicit fentanyl drives the overdose crisis. Chronic pain patients face collateral damage from restrictive policies, while harm reduction and international supply-chain interventions remain underprioritized. Effective solutions require:
– Reallocating settlement funds to **patient access programs** and **illicit drug interdiction**.
– Pressure on China and Mexico to disrupt precursor networks ([4][8]).
– Revisiting CDC/DEA guidelines to prevent nonmedical opioid use without penalizing legitimate patients ([1][2][3]).

Until policymakers confront the synthetic opioid pipeline and balance supply-side enforcement with patient-centered care, overdose rates will likely remain elevated.

Citations:
[1] https://www.mbc.ca.gov/Download/Publications/pain-guidelines.pdf
[2] https://www.cdc.gov/overdose-prevention/hcp/clinical-guidance/recommendations-and-principles.html
[3] https://titangroupdea.com/blog/new-opioid-regulations-pain-management-specialists-need-to-know-about-2025?hsLang=en
[4] https://www.brookings.edu/articles/the-fentanyl-pipeline-and-chinas-role-in-the-us-opioid-crisis/
[5] https://www.npr.org/2025/02/02/nx-s1-5283957/fentanyl-trump-tariffs-china-canada-mexico
[6] https://www.thinkglobalhealth.org/article/how-overdose-prevention-centers-became-political-scapegoats
[7] https://www.npr.org/2023/12/28/1220881380/overdose-fentanyl-drugs-addiction
[8] https://www.cfr.org/backgrounder/fentanyl-and-us-opioid-epidemic
[9] https://pmc.ncbi.nlm.nih.gov/articles/PMC5565130/
[10] https://ldi.upenn.edu/our-work/research-updates/partisan-politics-and-the-opioid-epidemic-a-social-media-analysis/
[11] https://www.humhealth.com/blog/chronic-pain-management-cpt-codes-and-billing-guide-2025/
[12] https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm
[13] https://www.aafp.org/family-physician/patient-care/care-resources/pain-management/aafp-chronic-pain-management-toolkit.html
[14] https://docrx.com/2025-billing-updates-for-non-opioid-pain-treatments-key-takeaways-for-healthcare-providers/
[15] https://www.ncbi.nlm.nih.gov/books/NBK92054/
[16] https://www.aafp.org/family-physician/patient-care/clinical-recommendations/all-clinical-recommendations/opioid-prescribing.html
[17] https://nacns.org/wp-content/uploads/2025/02/Pain-Management_2025_02_04_FINAL-.pdf
[18] https://www.azdhs.gov/documents/prevention/womens-childrens-health/injury-prevention/opioid-prevention/appendix-b-state-by-state-summary.pdf
[19] https://end-overdose-epidemic.org/wp-content/uploads/2020/07/Principles-of-Evidence-Informed-Pain-Care-FINAL_template-1.pdf
[20] https://painmed.org/clinical-guidelines/
[21] https://www.ncbi.nlm.nih.gov/books/NBK572085/
[22] https://www.ncbi.nlm.nih.gov/books/NBK553030/
[23] https://www.ncbi.nlm.nih.gov/search/research-news/19707
[24] https://www.congress.gov/event/118th-congress/house-event/115371/text
[25] https://www.dea.gov/sites/default/files/2020-03/DEA_GOV_DIR-008-20%20Fentanyl%20Flow%20in%20the%20United%20States_0.pdf
[26] https://www.wilsoncenter.org/article/lab-overdose-synthetic-opioid-crisis-shaping-us-mexico-agenda
[27] https://www.dea.gov/sites/default/files/2024-05/NDTA_2024.pdf
[28] https://www.pa.gov/agencies/ddap/overdose/opioid-overdose.html
[29] https://www.cbp.gov/border-security/frontline-against-fentanyl
[30] https://www.samhsa.gov/find-help/helplines/national-helpline
[31] https://www.whitehouse.gov/presidential-actions/2025/02/imposing-duties-to-address-the-flow-of-illicit-drugs-across-our-national-border/
[32] https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates
[33] https://fsi.stanford.edu/sipr/fentanyl-blame-game
[34] https://www.dea.gov/resources/facts-about-fentanyl
[35] https://pmc.ncbi.nlm.nih.gov/articles/PMC9838196/
[36] https://www.azag.gov/issues/opioids
[37] https://www.cdc.gov/overdose-prevention/about/understanding-the-opioid-overdose-epidemic.html
[38] https://www.naccho.org/programs/community-health/injury-and-violence/overdose/health-equity-drug-overdose-response
[39] https://www.hhs.gov/overdose-prevention/
[40] https://www.cbo.gov/publication/58532
[41] https://siepr.stanford.edu/publications/policy-brief/opioid-crisis-tragedy-treatments-and-trade-offs
[42] https://calmatters.org/explainers/california-opioid-crisis/
[43] https://www.apha.org/policies-and-advocacy/public-health-policy-statements/policy-database/2022/01/07/an-equitable-response-to-the-ongoing-opioid-crisis
[44] https://journalofethics.ama-assn.org/article/how-fda-failures-contributed-opioid-crisis/2020-08
[45] https://publichealth.jhu.edu/2024/nearly-one-third-of-us-adults-know-someone-whos-died-of-drug-overdose
[46] https://www.cdc.gov/mmwr/volumes/71/rr/rr7103a1.htm
[47] https://www.asahq.org/~/media/sites/asahq/files/public/resources/standards-guidelines/practice-guidelines-for-chronic-pain-management.pdf
[48] https://www.dir.ca.gov/dwc/DWCPropRegs/2025/MTUS-Evidence-Based-Update/Chronic-Pain-Guideline.pdf
[49] https://www.va.gov/painmanagement/docs/cpg_opioidtherapy_summary.pdf
[50] https://www.healthquality.va.gov/guidelines/pain/cot/
[51] https://nida.nih.gov/research-topics/opioids
[52] https://www.bbc.com/news/articles/cvg93nn1e6go
[53] https://www.canada.ca/en/health-canada/services/opioids/overdose.html
[54] https://medlineplus.gov/opioidoverdose.html
[55] https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0236815
[56] https://pmc.ncbi.nlm.nih.gov/articles/PMC9261968/
[57] https://www.ama-assn.org/system/files/ama-overdose-epidemic-report.pdf
[58] https://pmc.ncbi.nlm.nih.gov/articles/PMC5846593/


Answer from Perplexity: pplx.ai/share

Once Again, NO ONE is above the law – except those who are in charge of enforcing such laws

Please read Mark’s letter below.. Mark reached out to me some 8-9 yrs ago as the MT medical board was starting to “go after him.”

As I understand it, one or more large practices in Maine have decided that all pain pts will be treated with Buprenorphine for pain management.

In Reading the Maine’s Pain Management Policies. It would seem that -collectively – Maine’s legal and healthcare professionals are violating their own law in regards to at least Brandy.

Opioid Prescribing Limits**: Maine’s 2017 law restricts opioid prescriptions to ≤100 morphine milligram equivalents (MME)/day for chronic pain, with exceptions for palliative care, cancer, and substance use disorder treatment

Here is:  Maine’s Pain Management Policies

Maine’s approach to pain management does not mandate the universal use of buprenorphine for all pain patients, but its regulations encourage cautious opioid prescribing while allowing flexibility for evidence-based treatments. The literature supports buprenorphine’s efficacy in managing chronic pain, particularly in high-intensity cases, with studies showing sustained pain relief and reduced tolerance development. For patients with high CYP-450 metabolism, pharmacokinetic interactions are manageable and rarely clinically significant.

### Maine’s Pain Management Policies
– **Opioid Prescribing Limits**: Maine’s 2017 law restricts opioid prescriptions to ≤100 morphine milligram equivalents (MME)/day for chronic pain, with exceptions for palliative care, cancer, and substance use disorder treatment[1].
– **Non-Opioid First Approach**: Clinicians must prioritize non-opioid therapies and use “Universal Precautions” (risk assessment, monitoring) when prescribing controlled substances[2][3].
– **Buprenorphine in Practice**: While not explicitly mandated, buprenorphine is permitted under exceptions for medication-assisted treatment (MAT) and chronic pain[1][3].

### Buprenorphine’s Efficacy in Pain Management
– **Chronic Pain**:
– A 36-month study of transdermal buprenorphine patches demonstrated sustained pain reduction (NRS scores decreased by 4.2–5.1 points) and high patient satisfaction (PGIC scores improved by 76%)[5].
– Systematic reviews found buprenorphine rotation from full opioids maintained or improved analgesia in 53–83% of patients, with fewer adverse effects than traditional opioids[10].
– **High-Intensity Pain**:
– Perioperative protocols recommend continuing buprenorphine and supplementing with short-acting opioids for acute pain, as abrupt discontinuation risks withdrawal[4].
– Partial agonism at µ-opioid receptors provides a “ceiling effect,” reducing respiratory depression risk while maintaining analgesia[11].

### CYP-450 Metabolism Considerations
– **Pharmacokinetics**: Buprenorphine is metabolized primarily by CYP3A4 and CYP2D6, with inhibitory effects on both enzymes[6][7][13].
– **Drug Interactions**:
– **Inhibitors (e.g., ciprofloxacin)**: Increase buprenorphine exposure by 33–44% but are unlikely to require dose adjustments[8][12].
– **Inducers (e.g., rifampin)**: Reduce exposure by 28%, which may necessitate monitoring[8].
– **High/Ultra-High Metabolizers**: Limited data suggest therapeutic doses remain effective, as buprenorphine’s high receptor affinity offsets rapid metabolism[6][8].

### Key Recommendations
1. **Chronic Pain**: Consider transdermal buprenorphine for long-term management due to its stable efficacy and low tolerance risk[5][10].
2. **CYP-450 Interactions**: Monitor patients on concurrent CYP3A4 inhibitors/inducers, though dose adjustments are rarely needed[8][12].
3. **Acute Pain**: Maintain buprenorphine and add short-acting opioids rather than discontinuing therapy[4].

Buprenorphine’s pharmacological profile and clinical evidence position it as a safer alternative to full opioids, aligning with Maine’s emphasis on risk mitigation without compromising pain control.

Citations:
[1] https://academic.oup.com/ajhp/article/73/12/854/5101528
[2] https://regulations.justia.com/states/maine/02/380/chapter-21/section-380-21-4/
[3] https://www.maine.gov/boardofnursing/laws-rules/Chapter%2021%2005.27.20.pdf
[4] https://www.painphysicianjournal.com/current/pdf?article=NTAwMQ%3D%3D&journal=109
[5] https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1454601/full
[6] https://pubmed.ncbi.nlm.nih.gov/12756210/
[7] https://www.jstage.jst.go.jp/article/bpb/25/5/25_5_682/_pdf
[8] https://pubmed.ncbi.nlm.nih.gov/33750027/
[9] https://www.themainewire.com/2025/02/mainecare-spending-on-suboxone-has-surged-since-2019/
[10] https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2784021
[11] https://en.wikipedia.org/wiki/Buprenorphine
[12] https://www.drugs.com/drug-interactions/buprenorphine-with-ciprofloxacin-438-0-672-0.html?professional=1
[13] https://go.drugbank.com/drugs/DB00921
[14] https://www.maine.gov/sos/cec/rules/10/144/ch101/c2s089.docx
[15] https://library.samhsa.gov/sites/default/files/pep21-06-01-002.pdf
[16] https://www.medicaid.gov/medicaid/section-1115-demonstrations/downloads/me-sud-care-initiative-midpoint-assessment-03282024.pdf
[17] https://mesudlearningcommunity.org/wp-content/uploads/2023/02/Prior-Authorization-Processes-Buprenorphine-FAQ-July2021.pdf
[18] https://lawatlas.org/sites/default/files/2025-03/VS%20Buprenorphine%20Policy%20Brief_March2025_final_3.26.25.pdf
[19] https://www.azdhs.gov/documents/prevention/womens-childrens-health/injury-prevention/opioid-prevention/appendix-b-state-by-state-summary.pdf
[20] https://www.maine.gov/boardofnursing/news.html?id=10822550
[21] https://www.mainehealth.org/care-services/behavioral-health-care/substance-use-disorder-care-addiction/opioid-use-disorder-care-mainehealth-behavioral-health/opioid-provider-resources-mainehealth-behavioral-health
[22] https://www.samhsa.gov/substance-use/treatment/find-treatment/buprenorphine-practitioner-locator
[23] https://www.federalregister.gov/documents/2025/01/17/2025-01049/expansion-of-buprenorphine-treatment-via-telemedicine-encounter
[24] https://www.mainehealth.org/health-care-professionals/clinical-guidelines-protocols/substance-use-disorder-clinical-guidelines
[25] https://pmc.ncbi.nlm.nih.gov/articles/PMC8163969/
[26] https://pmc.ncbi.nlm.nih.gov/articles/PMC8567798/
[27] https://pcssnow.org/wp-content/uploads/2022/03/PCSS-GuidanceTreatmentOfAcutePainInPatientsReceivingBup.Fiellin-SrivastavaUpdate_03_24_22.pdf
[28] https://www.ncbi.nlm.nih.gov/books/NBK459126/
[29] https://www.dovepress.com/frontline-perspectives-on-buprenorphine-for-the-management-of-chronic–peer-reviewed-fulltext-article-JMDH
[30] https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.2676
[31] https://academic.oup.com/painmedicine/article-abstract/25/12/691/7716541
[32] https://academic.oup.com/painmedicine/article/21/4/714/5699282
[33] https://www.va.gov/formularyadvisor/DOC_PDF/CRE_Buprenorphine_for_Chronic_Pain_MAR_2024.pdf
[34] https://www.tandfonline.com/doi/full/10.2217/pmt-2020-0013
[35] https://pmc.ncbi.nlm.nih.gov/articles/PMC4675640/
[36] https://pmc.ncbi.nlm.nih.gov/articles/PMC4283787/
[37] https://www.recoveryanswers.org/research-post/tried-true-methadone-shows-superiority-buprenorphine/
[38] https://www.tandfonline.com/doi/full/10.1080/00325481.2016.1128307
[39] https://www.oaepublish.com/articles/jtgg.2020.35
[40] https://www.bccsu.ca/wp-content/uploads/2022/06/Buprenorphine-Naloxone-Drug-Drug-Interactions.pdf
[41] https://www.jstage.jst.go.jp/article/bpb/25/5/25_5_682/_article/-char/en
[42] https://academic.oup.com/cid/article/43/Supplement_4/S216/282268
[43] https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1002/prp2.271
[44] https://legislature.maine.gov/legis/statutes/22/title22sec3174-UU.pdf
[45] https://micismaine.org/wp-content/uploads/2019-MICIS-Opioid-Law-Presentation-11.2019.pdf
[46] https://www.samhsa.gov/substance-use/treatment/statutes-regulations-guidelines/mat-act
[47] https://mainedrugdata.org/focus-area-2023-2025-treatment/
[48] https://pubmed.ncbi.nlm.nih.gov/38340973/
[49] https://pmc.ncbi.nlm.nih.gov/articles/PMC7709797/


Answer from Perplexity: pplx.ai/share

 

To whom it may concern:

Brandy Stokes reached out to me by referral through Steve Ariens.
At the time she was in the middle of a forced taper instituted by Eva Quirion, Np, DNP.
This was reported to be a “compassionate taper“, and indeed it was slow. But it was not compassionate. Brandy metabolizes  opiates and super rapid ultra metabolism.
Prior to the forced taper, she had been stable on 30 mg oxycodone 30 tablets a day. She was started on this regimen by all the smart doctors in Boston that took care of her after her ankle fracture osteomyelitis pick line sepsis, endocarditis valve replacement and diffuse complex regional pain syndrome.
Dr. Loeffler took care of her for over eight years and she was stable. Disabled but stable. She formally taught eighth grade. She raised three boys as a single mother, and I’ve never met anyone with the persistence and tenacity that this patient demonstrates.
At any rate, she was down to 22 tablets of 30 mg oxycodone a day and she was in active withdrawal:
She had blood pressure levels over 220/180.
Chest pain at a level above nine out of 10, and was forced to go to bed, unable to care for herself.
Naturally, she was suicidal at this time.
She’s a very religious person and would not or could not complete suicide without violating her most core values.
In considering taking her on as a Pain refugee,
I spoke to Dr. Loeffler, Dr. Adams , and nurse practitioner Matthews.
I spoke to her pharmacy, Hannaford pharmacy, and the pharmacist there was quite compassionate and eager to restore Brandy’s previous level of pain, relief and functionality.
I believe her name is Grace.
I queried Grace about the prescription drug registry and Grace! told me that Brandi had used one pharmacy and a stable dose of these pain pills for years. There were no early refills, etc.
She was highly trusted and highly responsible according to Grace the Hannaford pharmacist.
I asked Grace if she was willing to fill the prescription if I sent one in and she said yes.
I was then of course, disturbed saddened, and upset when the prescription was canceled by Dr Quirion. I did not think she had the authority to override a prescription from another physician. I suspected a HIPAA violation had occurred, and I immediately reported it to the board of pharmacy in Maine.
Hannaford then pharmacy refused to fill any prescription from me for Brandy.
At this point, she was having trouble keeping her blood pressure under control and she couldn’t get anyone to fill her blood pressure medication’s either.
We were able to find a Walgreens pharmacy to Phil one weeks worth of her medication’s to keep her alive.
Brandi had already notified Dr. query on that she was seeking help from someone who would treat her palliative care, under MAINe palliative care program B. ( due to Brandy’s advocacy. The palliative care program was already in place.)
I made it clear to the Hannaford pharmacy people and their supervisors up the line that I was considering that she was abandoned by this pharmacy, arbitrarily and capriciously.
At any rate for the next year, Brandi was able to beg and plead for one or two weeks of her life-saving medication from numerous compassionate pharmacies in Maine. That would only treat her for that one week or two.
Ultimately, she was able to find for herself a pharmacy in New Hampshire that would fill three weeks worth of her medication’s prescribed by me.
Brandi now travels four hours each way to New Hampshire to fill her prescriptions every three weeks.
Because of the severity of her pain and hypertension and flare of her complex, regional pain syndrome, Brandy developed swelling, blisters, and weeping lesions on her lower extremities, which were very difficult to manage and disqualify her from WATER physical therapy.
Once her pain management regimen was restored, she was able to heal these circumstances.
It took months for her legs to heal.
I attribute this difficult. To the interruption of her stable pain regimen. I suspect it also relates to the hypertension that was secondary to her pain. This hypertension was unfortunately unresponsive to the limited amount of blood pressure medicine. She was still able to use from her stash.
I SAY THIS IN NO UNCERTAIN TERMS: BECAUSE SHE WAS FIRED FROM THE ST. JOHN’S MEDICAL GROUP BY Eva, she was unable to get any of her standard medication‘s
In other words, she was completely abandoned for all her medical needs, would you curse to me as retribution.
She was given the diagnosis of chronic persistent, opioid dependence, CPOD.
There is no DSM code for this diagnosis and it is not been accepted by DSM five in the psychiatric diagnostic and statistical manual.( BY THIS I MEAN IT’S A NEW MADE UP DIAGNOSIS.)
It’s an unnecessarily redundant term given that her pain is chronic and persistent and her opioid dependence is obvious. She is dependent, but not addicted to the pain medication’s. That keep her alive.
In the time that I’ve been taking care of her, she has shown remarkable resilience and determination to stay alive.
She has been sorted by not having enough medication’s to travel to South Carolina to visit her two grandchildren, born 18 months and two weeks ago.
She’s dependent in many other ways also.:
She dependent on the generosity of random pharmacist throughout the state of Maine.
She depending on her son to drive her to New Hampshire every three weeks.
She’s depended on the compassion of her pharmacist in New Hampshire. Who sees many other Payne refugees from Maine who are not getting what they need.
And, of course, she’s dependent on my tenuous medical license.
The state of Maine sent me a cease and desist letter to get me to abandon Brandy.
We responded to the cease-and-desist letter by making sure that she and I meet in New Hampshire on video every time she gets her prescriptions filled in New Hampshire.
Brandy and I appeared on a panel discussing Pain Refugees with The Cato Institute, led by Dr Jeffrey Singer.
There are 
No more Pain  refugees in my practice that I can count.
Brandy is too strapped financially to pay for more than one or two of my visits over the last almost 2 years.
I have committed to standby Brandi as long as I possibly can. Because she’s lost three different providers, I’m aware that the same fate could land on me.
She has not been able to find anyone to assume her care within the state of Maine.
She’s not an addict.
An addict’s life falls apart when they take their substance.
A pain patient’s life comes back together when they get their relief.
Since her pain treatment has been restored, she’s become one of our leading advocates in the movement to protect patients in pain.
IF SHE LOSES HER PAIN CARE, HER RISK OF DEATH IS GREATER THAN 50%. HER BLOOD PRESSURE WAS OUT OF CONTROL AND SHE WAS NEAR DEATH WHEN I MET HER.
We have plenty of evidence of the harm caused to her by her forced  taper, which is categorically and undeniably counter to the flawed CDC guidelines of 2016 and 2022
I remain at Brandi’s service, and I remain in awe of her tenacity and commitment to not only help herself but the likely 400,000 people suffering in Maine from the same fate.
I am eager to speak with anyone who reads this.
I’m also eager to rebut any accusations made by the Attorney General of the state of Maine, who asked me to break main law by abandoning Brandy.
By the way, I am now fully compliant with the seasoned assist order. I’m no longer treating Brandy in the state of Maine. Her prescriptions are filled in New Hampshire and she stands on the ground in New Hampshire when I visit with her.
She and I have also met in person within the last month.
Be advised that I’ve been operating under the Covid emergency guidelines extended by the dea through 2025. This allows for telemedicine for scheduled prescriptions, which began during Covid. These guidelines have been extended annually for the last five years.
Here’s the science behind Genetic pleomorphism:
It’s settled science. Anyone ignoring the fact that some patients metabolize opiates in an ultra rapid fashion is in denial or lying.
According to multisystem reviews, the chance of addiction for pain medication’s is less than one percent.
Those claiming that pain pills lead to risk of overdose death ignore the risk of untreated pain.
Ask yourself this question:
If there’s over prescribing, then statistically there has to be under prescribing as well.
This is a term that’s never been defined by dea skateboards of Medicine or any critic of pain management
Feel free to see below my book and movie about these topics.
I stand by Brandi and I stand ready to assist anyone who reads this and understanding the cruel ignorant and evil campaign against her and her doctors.
MarkIbsenMD 
406–4 39–0752

 

Bestselling Author: Dr Bison’s Fables, An Allegory of The American Pain Refugee Crisis.
 CDC: “24-126 million Americans in chronic pain”
Pain Warriors 2020 documentary, international Award-Winner,  featuring Mark Ibsen MD

War on Doctors: Tricks Used in Prosecutions

War on Doctors: Tricks Used in Prosecutions

https://aapsonline.org/war-on-doctors-tricks-used-in-prosecutions/

This is a very long article about how our federal judicial system functions in getting any “targeted prescriber” convicted. To boil down their basic tactics… they raid and shut down a prescriber’s practice and confiscate all the prescriber’s assets under our Civil Asset Confiscation law. This leaves the prescriber with no income and no assets to hire an excellent law firm to defend the prescriber and maybe get the prescriber found not guilty.  I remember a particular prescriber in Montana who – as I remember – was charged with 400 counts over the patient records of 9 patients. Each count was worth a 20 yr prison sentence. The prescriber ended up using a PUBLIC DEFENDER and ended up pleading guilty to a single charge and ended up with a 20 yr prison term.

Dr. Chris Arthur Christensen, 68 y/o, a physician from Montana, was convicted and sentenced to prison for multiple violations of the Controlled Substances Act. His case involved serious allegations of improper medical practices, including the overprescribing of narcotics.

In 2015, Dr. Christensen faced 400 felony charges, including two counts of negligent homicide related to patient overdoses, nine counts of criminal endangerment, and hundreds of counts of illegal drug distribution. Investigators alleged that he prescribed controlled substances outside the scope of legitimate medical practice and operated a “cash-only” clinic that attracted patients from multiple states. Two patients reportedly died from overdoses linked to his prescriptions[1][2].

After a trial in 2017, Dr. Christensen was convicted on several counts, though his negligent homicide convictions were later overturned by the Montana Supreme Court due to insufficient evidence directly linking his actions to the deaths. However, the court upheld other convictions, including criminal endangerment and illegal drug distribution, as it found he was operating outside the bounds of professional medical standards[3].

In 2018, he was sentenced to 20 years in prison, with 10 years suspended. Following appeals, he began serving his sentence in November 2020[2].

Citations:
[1] https://www.dea.gov/es/node/4327
[2] https://doctorsofcourage.org/chris-a-christensen-md/
[3] https://law.justia.com/cases/montana/supreme-court/2020/da-18-0268-0.html
[4] https://www.casemine.com/commentary/us/montana-supreme-court-upholds-criminal-liability-for-physicians’-unlawful-drug-distribution-practices/view
[5] https://www.kpax.com/news/ravalli-county/former-florence-doctor-finally-behind-bars-4-years-after-conviction
[6] https://juddocumentservice.mt.gov/getDocByCTrackId?DocId=306890
[7] https://caselaw.findlaw.com/court/mt-supreme-court/2085987.html
[8] https://doctorsofcourage.org/chris-a-christensen-md-2/
[9] https://bitterrootstar.com/2020/09/montana-supreme-court-overturns-christensens-homicide-convictions/
[10] https://flatheadbeacon.com/2020/11/23/convicted-montana-pain-doctor-ordered-prison-march/
[11] https://medicalmalpracticelawyers.com/montana-supreme-court-overturns-negligent-homicide-convictions-of-opioid-prescribing-doctor/
[12] https://www.spokesman.com/stories/2020/sep/16/justices-overturn-doctors-convictions-in-overdose-/
[13] https://scholarworks.umt.edu/cgi/viewcontent.cgi?article=2497&context=mlr
[14] https://bitterrootstar.com/2017/11/guilty-verdict-in-opioid-over-prescription-case-an-analysis/



Answer from Perplexity: pplx.ai/share

 

By Andrew L. Schlafly, Esq.,

“Show me the man and I’ll find you the  crime”  is  a famous saying from the communist Soviet Union, where prosecutions of innocent people, and over-prosecutions of people for minor infractions, were routine.

Similar  sayings  have  existed  in  the  United  States,   as  in how a  prosecutor  can  persuade  a  grand  jury  to  “indict  a ham sandwich.”1 (Ironically, the judge who coined that expression was himself later indicted.) As  any  prosecutor can confirm, if a grand jury appears reluctant to issue an indictment requested by a prosecutor, then he can simply convene another grand jury, and then another, until he gets the indictment he wants.

So much for the safeguard of the grand jury as supposedly guaranteed by the Fifth Amendment to the U.S. Constitution: “No person shall be held to answer for a capital, or otherwise infamous crime, unless on a presentment or indictment of a grand jury.” The grim reality is that many prosecutors today have virtually unlimited power to decide whom to indict, with no meaningful check and balance by any grand jury. Occasionally there is news about a grand jury declining to indict someone in a high-profile case, such a shooting by police of an unarmed minority teenager, but even those decisions not to indict are typically the result of the prosecutor intentionally leading the grand jury to that conclusion. In cases where there is a public outcry and the prosecutor does not feel the evidence justifies a criminal indictment, then he can lead the grand  jury to  non-indictment,  and  the  public is better mollified by such a decision by  a  grand  jury than by a solitary prosecutor. But whenever a  prosecutor  wants an indictment against someone, then he will get it, as any prosecutor would confirm privately.

State and Federal Systems

The U.S. Constitution established a system of dual sovereignty, with the federal and state governments wielding power over their overlapping spheres of authority. Supreme Court Justice Anthony Kennedy  asserted  in  a  landmark case that the dual sovereignty enhances liberty, but many would dispute that. “Though on the surface the idea may seem counter-intuitive, it was the insight of the Framers that freedom was enhanced by the creation of two governments, not one.”2

In fact, the dual sovereignty means that the federal government can prosecute a defendant even after he was acquitted in state court for the very same conduct, despite the prohibition by the Double Jeopardy Clause in the Fifth

Amendment to the U.S. Constitution: “…nor shall any person be subject for the same offence to be twice put in jeopardy  of life or limb.” A physician who is acquitted of a crime  in state court could still be prosecuted for the same conduct in federal court, and it is important to be aware of fundamental differences between the two systems.

Originally, state court is where virtually all crimes were tried. “The Constitution grants the federal government jurisdiction over only three crimes: treason, counterfeiting, and piracy,”3 as Texas Rep. Ron Paul, M.D., famously observed on the floor of the U.S. House of Representatives. Everything else was tried exclusively in state court for most of American history.

In state  and  local  government,  there  is  a  check  on  that power in the form of political accountability for the prosecutor, and in the form of real limitations on the resources available. District Attorney offices are not overflowing with spare staff and extra funding, and local police do not have  the time or interest in pursuing nonexistent crimes. Out of political and economic necessity, real crimes take priority over political agendas. Prosecutors who overstep their role can be held accountable for it, as prosecutor Michael Nifong was for his role in the wrongful indictments of three Duke University lacrosse players for rape.

Additional factors tend to limit overzealous prosecution at the local  or  state  level.  Local  prosecutors  are  part  of the community in which they  work,  and  many  of  them grew  up  there.  They  have  long-time   acquaintances   in   the neighborhood on both sides of the law. These local prosecutors are typically not seeking publicity to propel an ambition to run for higher office, which might induce them  to seek targets for political purposes. Of course, there are some instances of prosecutorial abuse of power within the state and local system, as the Duke lacrosse case illustrated. Physicians too, such as Dr. James Graves in Florida, languish in prison for decades, possibly the rest of their lives, as  victims of a local prosecution that made them a scapegoat for a tragedy, often, as in the Dr. Graves case, related to drug abuse.

But many so-called“healthcare crimes” and other offenses are prosecuted in federal, not state courts today, contrary to the text of the U.S. Constitution. Federal prosecutions lack the essential checks and  balances in  the  state  system,  and  it is at the federal level at which the War on Doctors is at its worst. Resources available for these prosecutions are virtually unlimited, and there is almost no political accountability for overstepping reasonable bounds. Federal prosecutors are appointed, not elected, and have never been impeached by Congress, although they could be. The  only elected person in the chain of command of a federal prosecutor is the President, and no presidential election is likely to have its outcome determined based on the track record of a federal prosecutor.

An example of a widely criticized federal prosecution was the case against Aaron Swartz, a prodigy who while still a teenager had helped develop the widely used RSS service for individualized news feeds, and also Reddit, the immensely popular informational website.4  Aaron is no longer with us because the full weight and unlimited resources of federal prosecutors hounded him relentlessly, with threats of lengthy prison sentences, until he committed suicide shortly before trial. This was all because he had allegedly downloaded numerous copyrighted scientific articles at MIT, which he arguably had a right to do. As Professor Lawrence Lessig explained in a heartfelt criticism of the federal  prosecution  of Aaron:

The “property” Aaron had “stolen,” we were told, was worth “millions of dollars” — with the hint, and then the suggestion, that his aim must have been to  profit from  his crime. But anyone who says that there is money to be made in a stash of ACADEMIC ARTICLES is either an idiot or a liar. It was clear what this was not, yet our government continued to push as if it had caught the 9/11 terrorists red-handed [emphasis in original].5

Yet there was no political accountability for the federal prosecutors who perpetrated this, or the trial judge who allowed it. Unlike the state system, in which both face elections and other meaningful review of their records, federal criminal justices are insulated from political accountability.

With less publicity than the federal injustice against, and then tragedy of Aaron Swartz, numerous physicians  have also felt compelled to commit suicide when trapped in the vise of overzealous federal prosecution. Benjamin R. Moore, D.O., for example, had been working in locum tenens for 7 years when he was placed by an agency in a temporary job  at a chronic pain center in Myrtle Beach, S.C. Dr. Moore was the most conservative prescriber of opiates there, according to a letter he sent without avail to the U.S. Attorney General.6 It did not matter. Federal prosecutors went after numerous physicians in the  clinic and  charged them with conspiracy to distribute illegal drugs, which makes each defendant legally responsible for the actions of every other defendant. Another physician, Deborah Bordeaux, M.D., who had been working there for only 57 days, was initially sentenced to 8 years in jail, although she was fortunate enough to have the term reduced later in an unusual re-sentencing.7 Dr. Moore committed suicide before trial.

Many victims of overzealous prosecution in the federal system feel compelled to accept plea bargains or commit suicide, regardless of their guilt, because the odds of conviction in a federal trial are so high, and the prison sentences are so long if a jury does not acquit on each and every count of  an  indictment.  Unlike  state  court,  where  the odds of acquittal are substantial, in federal court the likelihood of an acquittal on all counts is only about one percent of all federal prosecutions brought.

Typically, federal prosecutors will pile on dozens or even hundreds of counts against a physician, and the jury may think it is holding mostly for the physician if it acquits on most of the charges. But the prison sentence is just as long    if a jury convicts on only one count out of 150 counts as if it had convicted on every count.

One federal prosecutor publicly declared that his office sought “to root out [certain doctors] like the Taliban. Stay tuned.”8 But physicians are not flying airplanes  into  the  World Trade Center. Physicians  are,  however,  much  easier  to prosecute than real criminals are. Physicians tend to cooperate with investigations, and will even readily admit shortcomings about their record-keeping   or   dealings with patients. Unlike real drug dealers, physicians trust undercover agents who wear wires attempting to entrap the target. Physicians also tend to consent to searches of their offices even when a government agent lacks a warrant.

The clincher for making physicians a top  target for federal prosecutors is this: indicting a physician grabs bigger headlines than indicting a real criminal does. The fall of a good man makes for a story that is scintillating to the public. More than a century ago Fyodor Dostoyevsky observed this same phenomenon in The Brothers  Karamazov:  “Man  loves to see the downfall and disgrace of the righteous.”9 The suggestion that a physician, a man of great trust in society, may actually be a horrific criminal is something that sells newspapers and attracts television viewers. The physician used his position of trust to exploit unsuspecting patients, the story goes, and a white knight in the form of a prosecutor protected society against the scoundrel by locking him up and throwing away the key.

If the physician were a real criminal, the case would be easy to prove, and it would not be necessary for a prosecutor to resort to any tricks to achieve his goal. Undercover sting operations, for example, would hardly be necessary if a physician were truly exploiting his position.

Trial by Jury
 

A brief history of trial by jury is necessary for readers to understand the tactics prosecutors use against physicians.

Jury trials are nearly unique to the Anglo-American system of jurisprudence, dating back to 13th-century England. Trial by jury originated not as improvement over trial by  judge,  but  to   replace   the   outdated   approaches of “compurgation” or “ordeal.” Under “compurgation,” a defendant could be acquitted of an accusation by obtaining a sufficient number of sworn statements by members of the community to support him. The “ordeal,” as its name implies, was less pleasant. It required the accused to stick his hand into a pot of boiling water to pick out a stone, while in the presence of clergy, and afterward his wound was observed for several days. The idea was seek divine intervention to give a sign as to guilt or innocence depending on how the wound festered or healed. By the 1200s the Church banned participation by clergy in this inhumane process, which was being used rarely and only for the most heinous alleged crimes anyway.

The rationale for switching to trial by jury was to give the community a voice in determination of  guilt or  innocence,  as the community (or God) were supposed to have in the ancient methods of compurgation and ordeal. All these methods contain an element of arbitrariness, some might say. Juries were not initially considered to be any more reliable, consistent, or rational than the approaches that trial by jury replaced. But juries are to speak with the voice of the community, or neighborhood, and to express their view with unanimity in order to convict.

The primary reason that the right to a trial by jury is  in  the  U.S.  Constitution,  however,  is  because  juries  provide an essential check against overzealous prosecutions by government. It was a jury that established  the  foundation for our First Amendment, in the criminal libel case brought against John Peter Zenger in 1735 for defaming the governor of New York, William Cosby.10 That remarkable jury trial also set the precedent for the American doctrine that truth is an absolute defense against  a  charge  of  defamation.  Zenger in his New York Weekly Journal had published some highly critical assertions against the powerful governor, who then brought the full power of his government down  on  Zenger in retaliation. Truth was not recognized as a defense against   a charge of criminal defamation at that time, and conviction seemed inevitable. But Zenger’s lawyers Andrew Hamilton and William Smith, Sr., argued successfully, the jury acquitted Zenger, and American freedom of the press was born as a result.

Note that the Founders did not believe  in  democracy and never thought that the collective opinion of random members of society would yield  the  correct  answer  to  every question. Quite the contrary, the Founders were very skeptical of the public being able to do what is right and just. The Founders include a “right” to a  jury trial for  the  benefit of an accused, not a “requirement” of a jury trial. Then, as now, ordinary people are vulnerable to the influences of demagoguery, prejudice, and careless error, as the Founders were well aware.

No Right to a Trial by a Judge?

The Constitution’s Sixth Amendment states:

In all criminal prosecutions, the accused shall enjoy the right to a speedy and public trial, by an impartial jury of the State and district wherein the crime shall have been committed, which district shall have been previously ascertained by law, and to be informed of the nature and cause of the accusation; to be confronted with the witnesses against him; to have compulsory process for obtaining witnesses in his favor, and to have the Assistance of Counsel for his defence.11

This establishes a right, not a requirement, to have a jury trial.

In addition, the body of the original Constitution contains the following at Art. III, § 2:

The Trial of all Crimes, except in Cases of Impeachment, shall be by Jury; and such Trial shall be held in the State where the said Crimes shall have been committed; but when not committed within any state, the Trial shall be at such Place or Places as the Congress may by Law have directed.

This provision, although ostensibly requiring trial by jury in cases brought in federal court for the three crimes that the U.S. Constitution allowed the federal government to prosecute, is again obviously intended to protect the rights of the accused, not to protect the power of government.

In colonial America, defendants were able to waive their right to a jury trial in many areas, and in Maryland the prevailing standard for 150 years was to hold criminal trials before a judge rather than a jury. In 1930, the U.S. Supreme Court held in Patton v. United States that a criminal defendant has a right to waive trial by jury, but then the Court unjustifiably added that “before any waiver can become effective, the consent of government counsel and the sanction of the court must be had, in addition to the express and intelligent consent of the defendant.”12

Intuitively, most criminal defendants think they are better off with a jury  hearing  their  case.  The  instinctive  reaction of nearly everyone is to exercise their rights, as one might exercise his right to free speech when faced with an injustice.

But studies have shown that some defendants are better off choosing a trial before a judge than a jury, and clever attorneys realize that a trial by judge might be fairer than a trial by  jury,  particularly  when  the  government  is  relying  on demagoguery to advance its case. As the next section explains, the government is increasingly relying on arguments designed to inflame prejudice against physicians, rather than sticking only to facts relevant to a claim of wrongdoing.

The Federal Rules of Criminal Procedure states in its Rule 23 that:

  • Jury Trial. If the defendant is entitled to a jury trial, the trial must be by jury unless:
    • the defendant waives a jury trial in writing; (2) the government consents; and (3) the court

In other words, the Federal Rules deny a criminal defendant his right to have a non-jury criminal trial unless both the prosecutor and the court itself consent to the defendant’s request.

The constitutionality of  requiring  a  criminal  defendant  to have a jury trial was subsequently tested and decided in   an unfortunate way. A defendant was convicted of a mail  fraud scam “to dupe amateur songwriters into sending him money for the marketing of their songs,” and the defendant appealed on this issue as a way to get out of his conviction.13 He requested a non-jury trial “for the purpose of shortening the trial,” rather than for a weightier reason such as to avoid prejudice against him by the jury. This case reached the

  • Supreme Court in 1964, when defendant-friendly Chief Justice Earl Warren was presiding, but he failed to recognize and address the significance of the issue. The “Warren Court,” as it was called, rendered many major decisions in favor of defendants, but missed its opportunity this

Writing for the Court, Chief Justice Warren correctly observed that criminal trials by jury were common at the time of the ratification of the Sixth Amendment. But evidently jury trials were not universal, or else there would have been little reason for the Founders to include the protection of a right to a jury trial. In missing obvious truths universally acknowledged with respect to other parts of the Constitution, such as how the right to free speech necessarily entails the right not to speak, the Court ruled that a constitutional right to have a jury trial does not imply a right not to have a jury trial.

The Court first recounted several compelling arguments for a right to be able to waive a trial by jury:13, pp 25-26

  • “At common law the right to refuse a jury trial preceded the right to demand ”
  • “Both before and at the time our Constitution was adopted criminal defendants in this country had the right to waive a jury ”
  • “The provisions [in the Constitution] relating to jury trial are for the protection of the ”
  • “Since a  defendant  can  waive  other   constitutional rights without the consent of the Government, he must necessarily have a similar right to waive a jury trial and that the Constitution’s guarantee of a fair trial gives defendants the right to safeguard themselves against possible jury prejudice by insisting on a trial before a judge ”
  • “The Fifth, Sixth, Ninth, and Tenth Amendments are violated by placing conditions on the ability to waive trial by ”

Yet the Warren Court rejected all the above arguments and held that both a federal prosecutor and the court itself each has a veto right over a defendant’s attempt to waive a trial by a jury that may be prejudiced against him.

Accordingly, federal prosecutors know that they can always insist on a trial by jury, and they tailor their prosecutorial strategy accordingly. Irrelevant or inflammatory arguments that should never persuade a judge could potentially mislead a jury to convict. With that in mind, we turn to the latest tricks and traps in the prosecutions of physicians.

Tricks and Traps in Prosecutions of Physicians

“Just the facts, ma’am,” is the  famous phrase attributed to Sgt. Joe Friday, the detective played by Jack Webb in the popular TV series Dragnet that  portrayed  law  enforcement in glowing light in the 1950s and 1960s. If prosecutors of

physicians properly stuck to“just the facts,”unjust convictions and unfair plea bargains would be less frequent.

Unfortunately, some prosecutors go beyond the relevant facts in their quest for convictions, based on the end justifying the means. According to the utilitarian  mindset that is increasingly common in the federal criminal justice system, why does it matter whether the defendant is really guilty or not? The stated purpose of the prosecution and lengthy sentencing is to deter wrongdoing, and that goal is met whether a guilty or an innocent man is locked up. As  long as the public is persuaded that  a  crime occurred,  and  as long as the public is told that  the  criminal  was  caught and severely punished, the desired effect of deterrence is satisfied regardless of the underlying innocence of the man imprisoned.

Prosecutions of physicians today are typically accompanied by harsh public statements made by the government against the defendant physician. A recent news story about the federal prosecution of a Eugene J. Gosy, M.D., in the Buffalo area illustrates several tricks used in the war on doctors.14

  1. Statistical profiling: “He was the No. 1 prescriber in New York,” declared an agent in charge of the DEA’s office in Buffalo, to the press. The fallacy is that there will always be a “No. 1 prescriber in New York.”Why should that statistic shock anyone? Yet it does tend to prejudice the average person who hears After prosecutors destroy the No. 1 prescriber in a state, then the No. 2 prescriber will become No. 1. Will that statistic make him guilty too? Of course not. Moreover, high volume does not imply guilt. Popularity breeds more popularity, in any line of work. The company Apple is not guilty of anything because its iPhone is popular.
  2. Saying the doctor was “out of the country” when prescriptions were written: This allegation is a favorite of prosecutors, and we’ve seen it used again and again against They compare billing records to the physician’s passport, and check the dates against each other. The argument sparks jealously and improperly creates a picture of a supposedly cavalier attitude by the  traveler. The  fallacy is that nothing wrongful can  be  inferred  about  someone for merely traveling outside of the country. Sometimes that world travel is to establish contacts for medical mission trips to impoverished lands; other times the travel is merely  to visit family in a foreign country. But even if the travel were pure leisure, that is not a bad thing that should be used to create prejudice. The government could simply say that the physician was not in the office, rather than smearing him by saying he was out of the country. Moreover, mistaken dates in billing records are inevitable, particularly in a high-volume practice. In a prior civil lawsuit against a physician, the government claimed he billed more than 24 hours in a day, when it was merely a mistaken billing date that was the reason.
  1. Trumpeting the doctor’s wealth—such as a “$126,000 Ferrari and a $103,000 Ford GT coupe”: The government seized these  assets  and  apparently  told  the  newspapers  all about it, so it was featured prominently in the publicity against the physician. The fallacy is that it is not a crime for a successful practicing physician to earn money and spend it on a nice car or two. The type of car that a physician drives is not evidence of any wrongdoing. Prosecutors commonly exploit class warfare in their war on doctors. The government wants to portray the physician as obscenely wealthy and incredibly greedy, for prejudicial effect. The reality is that practicing physicians, even the  highest compensated ones,  make only  a pittance compared with insurance company executives, while working many times harder than executives do. An executive at a specialty society profiting from Maintenance  of Certification (MOC) has publicly bragged about his rare car collection, yet the government has taken no action against him.
  1. Emphasizing the large sum of false claims alleged, say “more than $241,000”: Prosecutors and the newspaper report such a number as though it is shocking, but  they omit the all-important The fallacy is that the absolute amount of alleged fraud is virtually meaningless unless represented as a percentage of total billings. If a physician billed $25 million over five years, then the alleged fraud of $241,000 is less than 1 percent of his billings. Error rates in most billing services are probably higher than that. By failing to  disclose  the  denominator,  the  publicity  fails to mention that the allegation is  merely  that  1  percent  of his billings were fraudulent. The public would be far less impressed by an allegation of an error rate of 1 percent than by an alleged amount of $241,000.
  2. Mentioning that “Like [the indicted physician], five other doctors have found themselves investigated,” and two of them pled guilty: The fallacy is that physicians often plead guilty because they face life in prison, or at least 20 years, if they take a case to trial and a jury mistakenly finds them Moreover, taking a case to trial can cost millions of dollars. When innocent physicians are offered plea bargains of less than 10 percent of the lengthy prison sentences, and can avoid a million-dollar loss to their retirement assets, then innocent physicians might plead guilty. An offer of only 2 or 3 years in prison can look very good to an innocent physician whose assets have  been seized and  who  cannot even  hire   a good attorney to  defend  himself.  The  guilty  plea  does not mean the defendant was really guilty, as the negative publicity falsely implies.

Effect on the Community

At the time of this writing, Dr. Gosy is awaiting trial with his New York medical license intact but his ability to practice crippled by the negative publicity against him and loss of his DEA registration to prescribe controlled substances. Despite the vigorous public relations effort by the government that thoroughly smeared Dr. Gosy’s reputation, the reaction by the community was swift and intensely negative against the government.  Dr.  Gosy  was  forced  by  the  indictment to close his practice, which stranded between 8,000 and 10,000 active patients in need of pain medications. Other physicians are obviously terrified to treat them with the threat of decades in prison hanging over them if they do. “At this point, we’re at a public health crisis,” observed Dr. Gale R. Burstein, county health commissioner.15 But this prosecution is by the federal government, and federal officials have no accountability for the devastating effect this has caused to the local community.

Conclusion

The Founders would  be  shocked at  the  degree  to  which the federal government is pursuing prosecutions of physicians and others, and the tactics employed to attain convictions. At least physicians can become more aware of the tricks being used.

Andrew L. Schlafly, Esq., serves as general counsel to AAPS. Contact: aschlafly@aol.com.

REFERENCES

  1. Levin J. The judge who coined “indicting a ham sandwich” was himself indicted. Slate, Nov 25, 2014. Available at: slate.com/blogs/lexicon_ valley/2014/11/25/sol_wachtler_the_judge_who_coined_indict_a_ ham_sandwich_was_himself_indicted.html. Accessed May 27, 2016.
  2. United States Lopez, 514 U.S. 549, 576 (1995) (Kennedy, J., concurring).
  3. Paul R. Crime. Book of Ron Paul. 2000 Ron Paul 71:5. Available at: http:// ronpaulquotes.com/concordance/crime.html. Accessed May 27,
  4. Bombardieri The inside story of MIT and Aaron Swartz. Boston Globe, Mar 30, 2014. Available at: https://www.bostonglobe.com/metro/2014/03/29/ the-inside-story-mit-and-aaron-swartz/YvJZ5P6VHaPJusReuaN7SI/story. html. Accessed May 28, 2016.
  5. Lessig L. Prosecutor as bully. LESSIG Blog, v2. Available at: http://lessig.com/post/40347463044/prosecutor-as-bully. Accessed May 28, 2016.
  6. Moore B. Letter to Attorney General John Ashcroft. Available at: aapsonline.org/painman/mooreashcroft.htm. Accessed May 28, 2016.
  7. Victimized Doctors. Available at: http://deasucks.com/essays/docwar3. Accessed May 28, 2016.
  8. Serkes K. Administration Declares war on doctors — vows to treat like Taliban. Drug war ensnares doctors, not dealers. Press Release. Available at: aapsonline.org/press/hurwitz929.htm. Accessed May 28, 2016.
  9. Dostoevsky Chapter 2. The Brothers Karamazov. Translated by Constance Garnett. Available at: www.magister.msk.ru/library/dostoevs/dostf01e. htm. Accessed May 28, 2016.
  10. John Peter Zenger Trial; 1735. Available at: http://law2.umkc.edu/faculty/ projects/ftrials/zenger/zenger.html. Accessed May 28,
  11. Sixth Amendment. U.S. Constitution. Available at: http://constitution.com/amendment6.html#sthash.MNPP2yPO.dpuf. Accessed May 28, 2016.
  12. Patton United States, 281 U.S. 276, 312 (1930).
  13. Singer United States, 380 U.S. 24, 25 (1965).
  14. Fairbanks Amherst pain doctor faces federal charges. Buffalo  News, Apr 26, 2016. Available at: www.buffalonews.com/city-region/ amherst-pain-doctor-faces-federal-charges-20160426. Accessed May 28, 2016.
  15. Tan ‘What are we supposed to do?’ opioid patients ask after feds shut down doctor. Buffalo News, May 5, 2016. Available at: www.buffalonews. com/city-region/what-are-we-supposed-to-do-opioid-patients-ask- after-feds-shut-down-doctor-20160505. Accessed May 28, 2016.

Employee shot and killed at Walgreens in Madera identified

MADERA, Calif. (KFSN) — The employee who was shot and killed at a Walgreens in Madera on Monday has been identified as Erick Velasquez.

Police say the shooting happened at the location on Cleveland and Schnoor just after 9:30 pm.

EDITOR’S NOTE: The video above is from a previous broadcast and will be updated.

When police arrived, they found Velasquez inside the store, where he was pronounced dead.

Police say the suspect, Narciso Gallardo Fernandez, went to Madera from Pixley and went inside the store with a handgun.

After the shooting, police say Fernandez fired at other employees as they were leaving the store. No one else was hit.

He was taken into custody in the parking lot.

Customers were also inside the store at the time of the shooting.

Police do not believe that Velasquez and Fernandez knew each other.

Walgreens released a statement on the incident, saying, “We are deeply saddened by last night’s tragic event, which resulted in the death of one of our team members. Our thoughts and prayers are with their loved ones during this difficult time. The safety of our customers and team members is our top priority, and we are working with local authorities in their investigation.”

Anyone with more information is asked to contact police.

When are disabled people going to get a DAY OF VISIBILITY? Where is the equity?

Today is

Transgender Day of Visibility: Honoring Trans Heroes and Sharing Stories of Resilience

https://www.hrc.org/press-releases/transgender-day-of-visibility-honoring-trans-heroes-and-sharing-stories-of-resilience

According to this:

Approximately 1.6 million people in the United States identify as transgender, representing around 0.6% of the population aged 13 and older. This includes about 1.3 million adults (0.5% of the adult population) and 300,000 adolescents aged 13 to 17 (1.4% of that age group)136.

While estimates vary slightly depending on the methodology and data source, this figure is consistent across multiple studies and surveys, including those conducted by the Williams Institute and other research organizations159.

Citations:

  1. https://www.newsweek.com/how-many-transgender-people-athletes-living-united-states-2030241
  2. https://pmc.ncbi.nlm.nih.gov/articles/PMC5227946/
  3. https://williamsinstitute.law.ucla.edu/wp-content/uploads/Trans-Pop-Update-Jun-2022.pdf
  4. https://apnews.com/article/how-many-transgender-intersex-laws-0218b75a197f07d8c51620bb73495d55
  5. https://www.nbcmiami.com/news/local/politifact-how-many-trans-people-are-there-in-the-u-s-and-why-do-we-overestimate-it/3074621/
  6. https://williamsinstitute.law.ucla.edu/publications/trans-adults-united-states/
  7. https://usafacts.org/articles/what-percentage-of-the-us-population-is-transgender/
  8. https://www.pewresearch.org/short-reads/2022/06/07/about-5-of-young-adults-in-the-u-s-say-their-gender-is-different-from-their-sex-assigned-at-birth/
  9. https://www.reuters.com/world/us/new-study-estimates-16-million-us-identify-transgender-2022-06-10/

Answer from Perplexity: pplx.ai/share

According to www.perplexity.ai:

The number of people in the United States considered disabled varies depending on the criteria and data source:

  1. Adults with Disabilities: Over 70 million adults in the U.S., or more than 1 in 4 (28.7%), reported having a disability in 2022, according to the CDC’s Behavioral Risk Factor Surveillance System17.

  2. All Ages (Non-Institutionalized Population): Approximately 42.5 million Americans, or 13% of the civilian noninstitutionalized population, had a disability in 2021, based on U.S. Census Bureau data310.

  3. Survey of Income and Program Participation (SIPP): This survey estimates that around 54 million Americans have a disability, though it uses broader definitions and methodologies4.

  4. Working-Age Population (18–64): About 22 million working-age Americans (11% of this demographic) reported having a disability in 2022, according to the American Community Survey5.

These figures highlight differences in how disabilities are defined and measured across various surveys and contexts.

Citations:

  1. https://www.cdc.gov/media/releases/2024/s0716-Adult-disability.html
  2. https://www.ssa.gov/policy/docs/statcomps/di_asr/2021/sect01.html
  3. https://www.pewresearch.org/short-reads/2023/07/24/8-facts-about-americans-with-disabilities/
  4. https://adata.org/faq/how-many-people-united-states-have-disability
  5. https://askearn.org/page/statistics-on-disability
  6. https://www.researchondisability.org/sites/default/files/media/2024-03/2024-annual-report-a11y-1.pdf
  7. https://www.cdc.gov/disability-and-health/articles-documents/disability-impacts-all-of-us-infographic.html
  8. https://www.census.gov/newsroom/facts-for-features/2024/disabilities-act.html
  9. https://miusa.globaldisabilityrightsnow.org/infographic/disability-usa/
  10. https://www.census.gov/library/stories/2023/06/disability-rates-higher-in-rural-areas-than-urban-areas.html

Answer from Perplexity: pplx.ai/share

Did you know that the primary FDA medication that is used by females who wish to transition to being a male? TESTOSTERONE – A C-3 CONTROLLED SUBSTANCE. The DEA – to date – has not imposed any pharma production limitations. Apparently, the only reason that it is classified as a C-3 is to try to prevent/limit athletes and bodybuilders from using it. 

There is nothing that ever suggested that politicians and bureaucrats function with logic and common sense.

Have you ever been ASKED?

Have you ever been asked by your practitioners and/or a staff member?

Have you ever considered harming yourself?

In all the years that I have been doing my blog, I now notice that the number of ESTIMATED suicide and attempted suicides published by the CDC has remained unchanged. 2012 when I started my blog, and today the USA population abt 9%. Mental health issues tend to be a rather fixed percentage of a population.

It is also interesting that around 2010-2012 is when the Rx opioids peaked, and today, the number of Rx opioids has been reduced abt 50%.

We know that many chronic pain patients have committed suicide because their pain meds have been involuntarily reduced, and an untold number of PREMATURE DEATHS from various reasons caused by under/untreated pain. While those numbers may or may not be documented, I have not seen a number being published.

Does this STRONGLY SUGGEST that there is a COVERT GENOCIDE going on?

Maybe chronic pain pts should take a copy of the graphic below with them to their doctor’s appointment?

When ASKED THE QUESTION… Suicide ideation can be caused by increased anxiety and depression, which can be caused by chronic pain pt’s pain management being forcibly reduced.

Should the chronic pain pt’s answer to THE QUESTION BE?

It may all depend on how much my pain management is reduced! Point to the bottom line on the chart! Might say something about the fact that aren’t doctors/practitioners supposed to be HEALERS?  As my pain management is reduced, I can expect the average intensity of my pain to increase, and my QOL is going to be compromised. I don’t look forward to being under “house arrest” because my pain will confine me to my house, chair, or bed. The CP pt might also express their concerns about all the other comorbidity issues that may be made worse and/or cause the pt to experience NEW COMORBITIY ISSUES not top of all the comorbidity issues they are already dealing with.

Right now, I can answer the questions with a NO, but suicide is generally somewhat impulsive. As my QOL deteriorates in line with my pain management being reduced, I can’t say what tomorrow brings.